Inspire Veterinary Partners, Inc. (IVPR) Stock Price & Analysis
Inspire Veterinary Partners, Inc. (IVPR) fell 7.14% to USD 0 as of June 10, 2026 at 02:52 UTC, according to Nexqual real-time market data.
IVPR last closed at USD 0; the session ranged USD 0–0 on volume of 618,264 shares. Market capitalization is $154,678, with a 52-week range of USD 0–2.02 (PNK). Source: Nexqual, June 10, 2026 at 02:52 UTC.
Key Statistics (as of June 10, 2026 at 02:52 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 7.14% (down) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 2.02 |
| Volume | 618,264 shares |
| Market Cap | $154,678 |
| Exchange | PNK |
Technical Analysis (IVPR)
Nexqual's technical model rates IVPR "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 24.42 (oversold) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (IVPR)
Wall Street analysts rate IVPR "None", per Nexqual as of June 10, 2026 at 02:52 UTC.
| Consensus Rating | None |
|---|
Earnings (IVPR)
Source: Nexqual, June 10, 2026 at 02:52 UTC.
Financials & Fundamentals (IVPR)
| Total Revenue | $15.56M |
|---|---|
| Revenue Growth (YoY) | +6.60% |
| Gross Margin | +19.36% |
| Operating Margin | -45.58% |
| Profit Margin | -76.75% |
| ROE | -331.80% |
| Debt / Equity | 410.61 |
| Current Ratio | 0.39 |
| Total Cash | $2.91M |
| Total Debt | $17.12M |
| Free Cash Flow | $-129,976 |
Source: Nexqual, June 10, 2026 at 02:52 UTC.
Financial Health Score (IVPR)
Nexqual rates Inspire Veterinary Partners, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:52 UTC.
| Growth | Solid — Revenue +7% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Critical — $3M cash vs $17M debt |
| Cash Flow | Weak — FCF negative: -$130K, burning cash |
| Efficiency | Critical — ROE -332%, ROA -24.0% |
Ownership (IVPR)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.06% |
| Shares Outstanding | 118.95M |
| Float | 6.69M |
| Short % of Float | +1.63% |
Source: Nexqual, June 10, 2026 at 02:52 UTC.
Leadership (IVPR)
Inspire Veterinary Partners, Inc. is led by Kimball Carr (age 54), Chairman, CEO & President, per Nexqual as of June 10, 2026 at 02:52 UTC.
| Chairman, CEO & President | Kimball Carr (age 54) |
|---|---|
| Chief Financial Officer | Richard Paul Frank (age 56) |
| Vice President of Operations | Laura Johnson (age 42) |
| Vice President of Medical Operations | Alexandra Quarti (age 50) |
From Inspire Veterinary Partners, Inc.'s Latest SEC 10-K Filing (filed 2025-03-31)
Partnerships
- Keiser on March 7, 2024.   1     General Release   On March 6, 2024, Inspire entered into a general release agreement with Kenneth Seth Lundquist, DVM, Charles "Chuck" Keiser, DVM, and Don I.
- A supplement to the prospectus contained in the Registration Statement filed with the Commission on October 22, 2024.   Spartan Capital Securities, LLC acted as the sole placement agent for the offering and received a fee of 8% of the gross proceeds, reimbursement of $25,000 in non-accountable expenses, and up to $75,000 in legal fees and out-of-pocket expenses, pursuant to a letter of engagement between the Company and Spartan.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ZAPPF | Zapp Electric Vehicles Group Li | USD 0 | ▲ 0% |
| ATPC | Agape ATP Corporation | USD 3.12 | ▲ 4.7% |
| CTNT | Cheetah Net Supply Chain Servic | USD 1.92 | ▲ 9.09% |
| LRHC | La Rosa Holdings Corp. | USD 1.05 | ▲ 0% |
| BDRX | Biodexa Pharmaceuticals plc | USD 3.1 | ▼ 7.74% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:52 UTC. This page is informational and not investment advice.